Patents by Inventor Werner Tschollar

Werner Tschollar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DIPEPTIDYLPEPTIDASE AND LEUCINE AMINOPEPTIDASE POLYPEPTIDE VARIANTS
    Publication number: 20230416716
    Abstract: The present disclosure relates to polypeptides with peptidase activity that are truncated variants of dipeptidylpeptidase IV (DPPIV) and leucine aminopeptidase (LAP) polypeptides, nucleic acids such as vectors encoding them, as well as host cells comprising the nucleic acids described herein and optionally expressing the polypeptides described herein. The polypeptides and nucleic acids described herein are useful in medical applications such as in the treatment of gluten-related disorders including celiac disease (CeD) and non-celiac gluten sensitivity (NCGS) as well as other diseases that may profit from a gluten-free diet (GFD).
    Type: Application
    Filed: October 25, 2021
    Publication date: December 28, 2023
    Inventors: Werner TSCHOLLAR, Silvia TIETZ
  • Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor
    Patent number: 6630502
    Abstract: A method is provided for slowing the progression of atherosclerosis in hypertensive or normotensive patients and reducing or eliminating atherosclerotic lesions in such patients by administering a combination of a cholesterol lowering drug such as pravastatin, and an ACE inhibitor, especially one containing a mercapto moiety, such as captopril or zofenopril.
    Type: Grant
    Filed: December 2, 1991
    Date of Patent: October 7, 2003
    Assignee: E.R. Squibb & Sons, Inc.
    Inventors: James L. Bergey, Werner Tschollar, Cary S. Yonce, James C. Kawano
  • METHOD FOR PREVENTING, STABILIZING OR CAUSING REGRESSION OF ATHEROSCLEROSIS EMPLOYING A COMBINATION OF A CHOLESTEROL LOWERING DRUG AND AN ACE INHIBITOR
    Publication number: 20030149101
    Abstract: A method is provided for slowing the progression of atherosclerosis in hypertensive or normotensive patients and reducing or eliminating atherosclerotic lesions in such patients by administering a combination of a cholesterol lowering drug such as pravastatin, and an ACE inhibitor, especially one containing a mercapto moiety, such as captopril or zofenopril.
    Type: Application
    Filed: December 2, 1991
    Publication date: August 7, 2003
    Inventors: JAMES L. BERGEY, WERNER TSCHOLLAR, CARY S. YONCE, JAMES C. KAWANO
  • Method for preventing onset of hypertension employing a cholesterol lowering drug
    Patent number: 5593971
    Abstract: A method is provided for preventing or reducing the risk of hypertension in normotensive patients having insulin resistance by administering a cholesterol lowering drug, such as pravastatin, alone or in combination with an ACE inhibitor, especially one containing a mercapto moiety, such as captopril or zofenopril.
    Type: Grant
    Filed: May 22, 1995
    Date of Patent: January 14, 1997
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Werner Tschollar, Cary S. Yonce, James L. Bergey, James C. Kawano
  • Method for treating hypertension employing a cholesterol lowering drug
    Patent number: 5461039
    Abstract: A method is provided for treating hypertension in normotensive patients having insulin resistance by administering a cholesterol lowering drug, such as pravastatin, alone or in combination with an ACE inhibitor, especially one containing a mercapto moiety, such as captopril or zofenopril.
    Type: Grant
    Filed: November 1, 1993
    Date of Patent: October 24, 1995
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Werner Tschollar, Cary S. Yonce, James L. Bergey, James C. Kawano
  • Method for preventing onset of hypertension employing a cholesterol lowering drug
    Patent number: 5298497
    Abstract: A method is provided for preventing or reducing the risk of hypertension in normotensive patients having insulin resistance by administering a cholesterol lowering drug, such as pravastatin, alone or in combination with an ACE inhibitor, especially one containing a mercapto moiety, such as captopril or zofenopril.
    Type: Grant
    Filed: June 1, 1992
    Date of Patent: March 29, 1994
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Werner Tschollar, Cary S. Yonce, James L. Bergey, James C. Kawano